Perinatal risk factors for early onset of Type 1 diabetes in a 2000-2005 birth cohort

C S Algert1, A McElduff, J M Morris

  • 1Kolling Institute of Medical Research, University of Sydney, Sydney. calgert@med.usyd.edu.au

Insights

Maternal Type 1 diabetes and being small for gestational age are key factors in early-onset Type 1 diabetes. Healthcare providers should consider size-for-gestational-age over birth weight for risk assessment.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes onset in children under six years old presents a significant public health concern.
  • Identifying perinatal risk factors is crucial for early intervention and prevention strategies.

Purpose of the Study:

  • To investigate perinatal risk factors associated with the onset of Type 1 diabetes in children before the age of six.
  • To analyze a large Australian birth cohort from 2000-2005 for early-onset Type 1 diabetes risk factors.

Main Methods:

  • Utilized linked delivery and hospital admission records from 2000-2007 for a cohort of 502,040 live births.
  • Identified Type 1 diabetes cases using International Classification of Diseases 10 (ICD-10) codes.
  • Analyzed perinatal factors including maternal diabetes, birth presentation (preterm birth, C-section), size-for-gestational-age, and maternal age.

Main Results:

  • Identified 272 hospital admissions for new-onset diabetes.
  • Maternal Type 1 diabetes significantly increased risk (RR 6.33).
  • Late preterm birth (RR 1.64), caesarean section (RR 1.30), and increasing maternal age (RR 1.13 per 5 years) were associated with increased risk.
  • Being small-for-gestational-age was protective (RR 0.48), while birth weight alone was not significant.

Conclusions:

  • Size-for-gestational-age is a more consistent predictor of early-onset Type 1 diabetes risk than birth weight.
  • Maternal Type 1 diabetes, late preterm birth, caesarean delivery, and advanced maternal age are significant perinatal risk factors.
  • Assessing size-for-gestational-age is recommended over birth weight thresholds for evaluating diabetes risk in young children.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...